LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Jap...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LONDON, Jan. 21, 2021 /PRNewswire-AsiaNet/ -- LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test. With approvals in Japan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test is now availabl...
Authors: LATEST ASIANET NEWS RELEASES